STAT November 6, 2024
Matthew Herper

Much will depend on Congress — and agency staffers

What will a second Donald Trump presidency mean for the regulation of medicines in the U.S.? History isn’t likely to repeat itself, but it will rhyme.

The first Trump presidency was marked by...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, FDA, Govt Agencies
Trump's health team has a trust issue
White House freezes all HHS communications, cancels meetings
The Drug-price Transparency for Consumers Act of 2025 Introduced
Funding for long-standing AIDS program at risk: 3 notes
Johnson bashes China on AI, Trump calls DeepSeek development "positive"

Share This Article